The 2024 BRACE Award Venture Competition Announced Three Semi-Finalists!

Important Updates! This coming Monday will be the Big Day of our 2024 BRACE Award Venture Competition. We are thrilled to announce the 3 Semi-Finalists competing this year, selected from a pool of 41 applications submitted by early-stage oncology companies from 10 different countries worldwide!

Congratulations to these outstanding scientist-entrepreneurs and their companies:

• Concarlo Therapeutics | Stacy Blain, Ph.D. | Founder & CEO
• NexCalibur Therapeutics | Minh-Duy Phan, Ph.D. | CEO & Scientific Co-Founder
• Orphagen Pharmaceuticals | Scott Thacher, Ph.D. | CEO

The 2024 BRACE Award Venture Competition is launched in collaboration with our partner organization, the Asian Fund for Cancer Research (AFCR), to accelerate innovative technologies that address cancers prevalent in underserved populations.

We would like to extend our heartful thanks to the selection and judging committee members for their tremendous support of the competition and invaluable contributions. We also want to say thank you to all of our dear supporters for helping advance that cause!